Concord Biotech Ltd. operates as a research and development based biotechnology company. The firm manufactures active pharmaceutical ingredients (API) through the process of fermentation, semi-synthetic and synthetic processes. Its products include APIs in the immunosuppressant, antibiotic, oncology, antifungal and hypolipemic segments and enzymes. The company was founded on November 23, 1984 and is headquartered in Ahmedabad, India.
Sector:
Commercial Services
Industry:
Miscellaneous Commercial Services
Employees:
1,571
Frequently Asked Questions
What is Market Cap of Concord Biotech Ltd.?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Concord Biotech Ltd. market cap is 127.79B.
What is the 52-week high for Concord Biotech Ltd.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Concord Biotech Ltd. 52 week high is 2,150.40 as of March 03, 2026.
What is the 52-week low for Concord Biotech Ltd.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Concord Biotech Ltd. 52 week low is 1,068.60 as of March 03, 2026.
What is Concord Biotech Ltd. stock price today?
Concord Biotech Ltd. stock price today is 1,192.50.
What was Concord Biotech Ltd. stock price yesterday?
Concord Biotech Ltd. stock price yesterday was 1,217.80.
What is the PE ratio of Concord Biotech Ltd.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Concord Biotech Ltd.'s P/E ratio is 40.2.
What is the Price-to-Book ratio of Concord Biotech Ltd.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Concord Biotech Ltd. P/B ratio is 6.8748.
What is the 50-day moving average of Concord Biotech Ltd.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Concord Biotech Ltd. 50-day moving average is 1,252.47.
How many employees does Concord Biotech Ltd. have?